Graft Loss
8
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Recipient Site Pre-conditioning in Fat Grafting
Effect of N-Acetylcysteine on Autologous Fat Graft Survival
Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection
Long-term Outcomes After Conversion to Belatacept
Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients
Factors Influencing Bone Block Allograft Resorption
The Impact of N-Acetylcysteine on Volumetric Retention of Autologous Fat Graft for Breast Asymmetry Correction
Graft Take and Microbiology in Burns